What the Options Market Tells Us About Amgen - Amgen (NASDAQ:AMGN)

What the Options Market Tells Us About Amgen - Amgen (NASDAQ:AMGN)

FY2025 EPS Estimates for Amgen Boosted by Cantor Fitzgerald

Amgen Inc. (NASDAQ:AMGN – Free Report) – Stock analysts at Cantor Fitzgerald increased their FY2025 earnings per share estimates for shares of Amgen in a report released on Friday, May 2nd. Cantor Fitzgerald analyst C. Gould now anticipates that the medical research company will earn $20.85 per share for the year, up from their previous […]

Amgen Exempts More States from 340B Contract Pharmacy Restrictions - 340B Report

Pharmaceutical giant Amgen is exempting providers in Utah, North Dakota and South Dakota from its 340B restrictions after those states [...] The post Amgen Exempts More States from 340B Contract Pharmacy Restrictions appeared first on 340B Report.